Literature DB >> 23997225

ICAM-1-dependent homotypic aggregates regulate CD8 T cell effector function and differentiation during T cell activation.

Nicholas A Zumwalde1, Eisuke Domae, Matthew F Mescher, Yoji Shimizu.   

Abstract

A hallmark of T cell activation in vitro and in vivo is the clustering of T cells with each other via interaction of the LFA-1 integrin with ICAM-1. The functional significance of these homotypic aggregates in regulating T cell function remains unknown. We used an APC-free in vitro activation system to demonstrate that stimulation of purified naive CD8 T cells results in enhanced expression of ICAM-1 on T cells that is sustained by the inflammatory cytokine IL-12 and associated with robust T cell aggregates. ICAM-1-deficient CD8 T cells proliferate normally but demonstrate a striking failure to aggregate. Interestingly, loss of ICAM-1 expression results in elevated levels of IFN-γ and granzyme B, as well as enhanced cytotoxicity. Similar results were obtained when anti-LFA-1 Ab was used to block the clustering of wild-type T cells. ICAM-1 ligation is not required for IFN-γ regulation, as clustering of ICAM-1-deficient CD8 T cells with wild-type T cells reduces IFN-γ expression. Analysis using a fluorescent reporter that monitors TCR signal strength indicates that T cell clustering limits T cell exposure to Ag during activation. Furthermore, T cell clustering promotes the upregulation of the CTLA-4 inhibitory receptor and the downregulation of eomesodermin, which controls effector molecule expression. Activation of ICAM-1-deficient CD8 T cells in vivo results in an enhanced percentage of KLRG-1(+) T cells indicative of short-lived effectors. These results suggest that T cell clustering represents a mechanism that allows continued proliferation but regulates T cell effector function and differentiation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23997225      PMCID: PMC3803108          DOI: 10.4049/jimmunol.1201954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Signals required for programming effector and memory development by CD8+ T cells.

Authors:  Matthew F Mescher; Julie M Curtsinger; Pujya Agarwal; Kerry A Casey; Michael Gerner; Christopher D Hammerbeck; Flavia Popescu; Zhengguo Xiao
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

Review 2.  Programming, demarcating, and manipulating CD8+ T-cell memory.

Authors:  Vladimir P Badovinac; John T Harty
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

3.  Organization of the integrin LFA-1 in nanoclusters regulates its activity.

Authors:  Alessandra Cambi; Ben Joosten; Marjolein Koopman; Frank de Lange; Inge Beeren; Ruurd Torensma; Jack A Fransen; Maria Garcia-Parajó; Frank N van Leeuwen; Carl G Figdor
Journal:  Mol Biol Cell       Date:  2006-07-19       Impact factor: 4.138

4.  Choice of resident costimulatory molecule can influence cell fate in human naïve CD4+ T cell differentiation.

Authors:  Kelli M Williams; Abby L Dotson; Amber R Otto; Jacob E Kohlmeier; Stephen H Benedict
Journal:  Cell Immunol       Date:  2011-08-27       Impact factor: 4.868

5.  Costimulation of naive human CD4 T cells through intercellular adhesion molecule-1 promotes differentiation to a memory phenotype that is not strictly the result of multiple rounds of cell division.

Authors:  Jacob E Kohlmeier; Marcia A Chan; Stephen H Benedict
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

6.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Nat Rev Immunol       Date:  2011-11-25       Impact factor: 53.106

7.  Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.

Authors:  Kathryn Trandem; Jingxian Zhao; Erica Fleming; Stanley Perlman
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

8.  The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells.

Authors:  Christina Eich; I Jolanda M de Vries; Peter C M Linssen; Annemiek de Boer; Jan B Boezeman; Carl G Figdor; Alessandra Cambi
Journal:  Immunol Cell Biol       Date:  2010-08-31       Impact factor: 5.126

9.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

Review 10.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

View more
  32 in total

1.  Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation.

Authors:  Matthew F Krummel; Jagdish N Mahale; Lion F K Uhl; Emily A Hardison; Adriana M Mujal; Julie M Mazet; Robert J Weber; Zev J Gartner; Audrey Gérard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

2.  ICAM-1 orchestrates the abscopal effect of tumor radiotherapy.

Authors:  Yang Zhao; Ting Zhang; Yanpu Wang; Dehua Lu; Jinhong Du; Xun Feng; Haoyi Zhou; Ning Liu; Hua Zhu; Shangbin Qin; Chenxin Liu; Xianshu Gao; Zhi Yang; Zhaofei Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

3.  Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes.

Authors:  Kate L Erickson; Michelle J Hickey; Yuki Kato; Colin C Malone; Geoffrey C Owens; Robert M Prins; Linda M Liau; Noriyuki Kasahara; Carol A Kruse
Journal:  J Vis Exp       Date:  2015-02-11       Impact factor: 1.355

4.  Development and characterization of CD54-targeted immunoPET imaging in solid tumors.

Authors:  Weijun Wei; Dawei Jiang; Hye Jin Lee; Miao Li; Christopher J Kutyreff; Jonathan W Engle; Jianjun Liu; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-11       Impact factor: 9.236

5.  Substrate-bound CCL21 and ICAM1 combined with soluble IL-6 collectively augment the expansion of antigen-specific murine CD4+ T cells.

Authors:  Shimrit Adutler-Lieber; Irina Zaretsky; Helena Sabany; Elena Kartvelishvily; Ofra Golani; Benjamin Geiger; Nir Friedman
Journal:  Blood Adv       Date:  2017-06-15

6.  Closed loop bioreactor system for the ex vivo expansion of human T cells.

Authors:  Matthew Li; Ling-Yee Chin; Syukri Shukor; Alfred Tamayo; Marcela V Maus; Biju Parekkadan
Journal:  Cytotherapy       Date:  2018-11-27       Impact factor: 5.414

7.  Adhesion- and Degranulation-Promoting Adapter Protein Promotes CD8 T Cell Differentiation and Resident Memory Formation and Function during an Acute Infection.

Authors:  Jessica K Fiege; Lalit K Beura; Brandon J Burbach; Yoji Shimizu
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

8.  Negative Regulation of Memory Phenotype CD8 T Cell Conversion by Adhesion and Degranulation-Promoting Adapter Protein.

Authors:  Jessica K Fiege; Brandon J Burbach; Yoji Shimizu
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

9.  Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.

Authors:  Yared Hailemichael; Amber Woods; Tihui Fu; Qiuming He; Michael C Nielsen; Farah Hasan; Jason Roszik; Zhilan Xiao; Christina Vianden; Hiep Khong; Manisha Singh; Meenu Sharma; Faisal Faak; Derek Moore; Zhimin Dai; Scott M Anthony; Kimberly S Schluns; Padmanee Sharma; Victor H Engelhard; Willem W Overwijk
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

10.  Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.

Authors:  Maksim Mamonkin; Malini Mukherjee; Madhuwanti Srinivasan; Sandhya Sharma; Diogo Gomes-Silva; Feiyan Mo; Giedre Krenciute; Jordan S Orange; Malcolm K Brenner
Journal:  Cancer Immunol Res       Date:  2017-10-27       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.